DEE29
MCID: DVL055
MIFTS: 37
|
Developmental and Epileptic Encephalopathy 29 (DEE29)
Categories:
Cancer diseases, Ear diseases, Eye diseases, Fetal diseases, Genetic diseases, Liver diseases, Mental diseases, Metabolic diseases, Neuronal diseases, Rare diseases, Respiratory diseases
|
|
MalaCards integrated aliases for Developmental and Epileptic Encephalopathy 29:
Characteristics:OMIM®:57 (Updated 05-Mar-2021)
Inheritance:
autosomal recessive
Miscellaneous:
onset at birth seizure onset in first months of life two unrelated families have been reported (last curated april 2015) HPO:31
developmental and epileptic encephalopathy 29:
Inheritance autosomal recessive inheritance Onset and clinical course congenital onset Classifications:
MalaCards categories:
Global: Genetic diseases Rare diseases Metabolic diseases Fetal diseases Cancer diseases Anatomical: Neuronal diseases Eye diseases Liver diseases Ear diseases Respiratory diseases Mental diseases |
OMIM® :
57
Developmental and epileptic encephalopathy-29 (DEE29) is an autosomal recessive neurologic disorder characterized by the onset of refractory myoclonic seizures in the first months of life. Affected individuals have poor overall growth, congenital microcephaly with cerebral atrophy and impaired myelination on brain imaging, spasticity with abnormal movements, peripheral neuropathy, and poor visual fixation (summary by Simons et al., 2015).
For a general phenotypic description and a discussion of genetic heterogeneity of DEE, see 308350. (616339) (Updated 05-Mar-2021)
MalaCards based summary : Developmental and Epileptic Encephalopathy 29, also known as epileptic encephalopathy, early infantile, 29, is related to deafness, autosomal recessive 89 and charcot-marie-tooth disease, axonal, type 2i. An important gene associated with Developmental and Epileptic Encephalopathy 29 is AARS1 (Alanyl-TRNA Synthetase 1), and among its related pathways/superpathways are Gene Expression and tRNA Aminoacylation. Related phenotypes are spasticity and failure to thrive Disease Ontology : 12 A developmental and epileptic encephalopathy characterized by onset in the first months of life of refractory myoclonic seizures, poor overall growth, congenital microcephaly with cerebral atrophy and impaired myelination on brain imaging, spasticity with abnormal movements, peripheral neuropathy, and poor visual fixation that has material basis in homozygous or compound heterozygous mutation in the AARS1 gene on chromosome 16q22. UniProtKB/Swiss-Prot : 73 Epileptic encephalopathy, early infantile, 29: A form of epileptic encephalopathy, a heterogeneous group of severe childhood onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent. EIEE29 patients manifest severe infantile epileptic encephalopathy, clubfoot, absent deep tendon reflexes, extrapyramidal symptoms, and persistently deficient myelination. |
Human phenotypes related to Developmental and Epileptic Encephalopathy 29:31 (show all 18)
Symptoms via clinical synopsis from OMIM®:57 (Updated 05-Mar-2021)Clinical features from OMIM®:616339 (Updated 05-Mar-2021) |
|
Articles related to Developmental and Epileptic Encephalopathy 29:
|
ClinVar genetic disease variations for Developmental and Epileptic Encephalopathy 29:6
UniProtKB/Swiss-Prot genetic disease variations for Developmental and Epileptic Encephalopathy 29:73
|
Search
GEO
for disease gene expression data for Developmental and Epileptic Encephalopathy 29.
|
Cellular components related to Developmental and Epileptic Encephalopathy 29 according to GeneCards Suite gene sharing:
Biological processes related to Developmental and Epileptic Encephalopathy 29 according to GeneCards Suite gene sharing:
Molecular functions related to Developmental and Epileptic Encephalopathy 29 according to GeneCards Suite gene sharing:
|
|